Using a $5 million grant from the Susan G. Komen for the Cure, researchers from the University of Kansas Medical Center will investigate whether flax seed can reduce or eliminate the risk for breast cancer. The grant is part of a $59 million portfolio of research grants that Komen will award scientists this year to search for cures for breast cancer.
The $5 million UKMC Promise Grant will be shared with the University of Texas at Austin to test flax seed on a group of premenopausal women ages 25-49 at moderate to high risk to develop breast cancer. The test will try to confirm the apparent reduction in cell growth and precancerous cells observed in an earlier pilot study.
Support group formed for lung ailments
The American Lung Association is starting a support group for people with chronic obstructive pulmonary disease and their families.
The group's first meeting will be at 2 p.m. Aug. 11 in Conference Room 2035 at Via Christi Hospital on St. Francis.
The topic will be a discussion and demonstration of oxygen equipment and traveling safely with oxygen.
Registration is requested by calling 316-689-5700.
Study: Breast cancer hits women of African descent hardest
A new study finds that African ancestry is linked to a more aggressive type of breast cancer that is more deadly.
Researchers at the University of Michigan Comprehensive Cancer Center in Ann Arbor found that, among women with breast cancer, 82 percent of African women had the breast cancer called "triple negative," 26 percent of African-Americans had the variety, and 16 percent of white Americans had it.
Triple negative breast cancer is negative for three markers used to determine treatment: the estrogen receptor, the progesterone receptor and HER-2/neu. Recent advances in breast cancer treatments target each of the receptors, but targeting all three is a major problem, said Lisa Newman, director of the Breast Care Center at the Comprehensive Cancer Center.
"Outcome disparities are therefore likely to increase, because fewer African-American women are candidates for these newer treatments," she said.
The study is in the online journal "Cancer."
—Los Angeles Times